Levodopa News and Research

RSS

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

Research suggests a new pathway for developing Parkinson's disease

There is currently no cure for Parkinson's disease (PD), and one of the main difficulties for developing treatments is that we don't know exactly how or why the disease occurs.

4 Jul 2022

Study uncovers a promising drug candidate to minimize dyskinesia in Parkinson's patients

A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson's disease.

1 Dec 2021

Northwestern scientists receive awards totaling nearly $18 million for Parkinson's disease research

Northwestern University scientists have received two awards totaling nearly $18 million for Parkinson's disease research from The ASAP Collaborative Research Network, a program of the Aligning Science Across Parkinson's (ASAP) initiative being implemented through The Michael J. Fox Foundation.

27 Oct 2021

Using deep brain stimulation to treat Parkinson’s Disease

News-Medical spoke to Dr. Aryn Gittis about her latest research into Parkinson's disease and how deep brain stimulation could be used to help treat it.

27 Oct 2021

Increased signaling by sonic hedgehog protein can inhibit LID in Parkinson's patients

Levodopa, or L-dopa, is considered the most effective treatment for Parkinson's disease today. After a few years of treatment, however, almost all patients develop a debilitating side-effect called L-dopa induced dyskinesia, or LID, which causes involuntary movements in the limbs, face, and torso. Deep brain stimulation can alleviate LID, but the procedure is highly invasive and not all patients are eligible.

23 Sep 2021

European study sheds light on the burden of Parkinson’s disease in patients and their carers

Results of a new European study published in the Journal of Parkinson's Disease may help improve clinical practice by shedding light on the lives of people with PD and their carers, re-emphasizing the many challenges they face in everyday life.

31 Aug 2021

Gene therapy shows promise in children with devastating genetic disorder

Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.

12 Jul 2021

Nanoscale coordination polymers show promise for efficient dopamine delivery in Parkinson's treatment

Parkinson's disease (PD) is a common neurodegenerative disorder caused by the death of dopaminergic neurons in a part of the brain (known as substantia nigra pars compacta), which leads to a deficit of dopamine (DA), one of the main neurotransmitters active in the central nervous system.

1 Jun 2021

New gel could be used as nasal spray for treating Parkinson's patients

Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson's disease.

25 May 2021

Step length synergy while crossing obstacles found to be lower in Parkinson’s patients

A multidisciplinary research group affiliated with the Department of Physical Education's Human Movement Laboratory at São Paulo State University in Bauru, Brazil, measured step length synergy while crossing obstacles in patients with Parkinson's disease and concluded that it was 53% lower than in healthy subjects of the same age and weight. Step length is one of the main variables affected by the disease.

7 Apr 2021

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown.

7 Jan 2021

Tomatoes could become a new, natural source of Parkinson's disease drug

Scientists have produced a tomato enriched in the Parkinson's disease drug L-DOPA in what could become a new, affordable source of one of the world's essential medicines.

9 Dec 2020

Experts review common and vexing issues affecting people with Parkinson's disease

Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society.

24 Sep 2020

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells.

17 Sep 2020

Levodopa News and Research

The currently available evidence on viral-induced parkinsonism

Research suggests a new pathway for developing Parkinson's disease

Study uncovers a promising drug candidate to minimize dyskinesia in Parkinson's patients

Northwestern scientists receive awards totaling nearly $18 million for Parkinson's disease research

Using deep brain stimulation to treat Parkinson’s Disease

Increased signaling by sonic hedgehog protein can inhibit LID in Parkinson's patients

European study sheds light on the burden of Parkinson’s disease in patients and their carers

Gene therapy shows promise in children with devastating genetic disorder

Nanoscale coordination polymers show promise for efficient dopamine delivery in Parkinson's treatment

New gel could be used as nasal spray for treating Parkinson's patients

Step length synergy while crossing obstacles found to be lower in Parkinson’s patients

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Tomatoes could become a new, natural source of Parkinson's disease drug

Experts review common and vexing issues affecting people with Parkinson's disease

Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

Parkinson's disease drug may improve vision in patients with age-related macular degeneration

New project improves timely administration of drugs to hospitalized Parkinson's patients

Research reveals mechanism underlying Parkinson's dyskinesia

Experimental drug offers hope for improving movement symptoms of Parkinson's

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News